Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid compo...

Full description

Saved in:
Bibliographic Details
Published inLipids in health and disease Vol. 20; no. 1; pp. 136 - 17
Main Authors Flores, Yvonne N., Amoon, Aryana T., Su, Baolong, Velazquez-Cruz, Rafael, Ramírez-Palacios, Paula, Salmerón, Jorge, Rivera-Paredez, Berenice, Sinsheimer, Janet S., Lusis, Aldons J., Huertas-Vazquez, Adriana, Saab, Sammy, Glenn, Beth A., May, Folasade P., Williams, Kevin J., Bastani, Roshan, Bensinger, Steven J.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 10.10.2021
BioMed Central
BMC
Subjects
Abuse
Adult
Aged
Alanine
Alanine transaminase
Alcohol abuse
Aspartate aminotransferase
Biomarkers
Biomarkers - blood
Blood lipids
Blood pressure
Body mass index
Case-Control Studies
Cholesterol
Cholesterol - blood
Chronic illnesses
Cirrhosis
Cohort Studies
Complications and side effects
Cross-sectional studies
Development and progression
Diabetes
Diabetes mellitus
Diagnosis
Drug abuse
Esters
Fatty acids
Fatty liver
Female
Genotypes
Glucose
Health aspects
Health care
Hepatitis
High density lipoprotein
Hispanic Americans
Humans
Laboratories
Lipid composition
Lipid metabolism
Lipidomics
Lipids
Liver cirrhosis
Liver diseases
Lysophosphatidylcholines - blood
Male
Measurement
Metabolic syndrome
Mexico
Middle Aged
NAFLD
Non-alcoholic Fatty Liver Disease - blood
Nonalcoholic fatty liver disease
Physiological aspects
Risk factors
ROC Curve
Serum lipids
Sphingomyelins - blood
Triacylglycerol desaturation
Triglycerides
Triglycerides - blood
Ultrasonic imaging
Ultrasound
Mexico
United States > US
Triacylglycerol desaturation
Mexican
NAFLD
Biomarkers
Lipidomics
Nonalcoholic fatty liver disease
Triglycerides
Cross-sectional study
Latinos
Online AccessGet full text

Cover

Abstract Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico. A nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves. NAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83. These preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD.
AbstractList Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico. Methods A nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves. Results NAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83. Conclusions These preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD.
Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico. Methods A nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves. Results NAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83. Conclusions These preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD. Keywords: Lipidomics, Triacylglycerol desaturation, Triglycerides, Nonalcoholic fatty liver disease, NAFLD, Biomarkers, Latinos, Mexican, Cross-sectional study
Abstract Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico. Methods A nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves. Results NAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83. Conclusions These preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD.
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico.BACKGROUNDNonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico.A nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves.METHODSA nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves.NAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83.RESULTSNAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83.These preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD.CONCLUSIONSThese preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD.
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico. A nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves. NAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83. These preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD.
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known risk factors include obesity, metabolic syndrome, and diabetes. The aim of this study was to better understand differences in the lipid composition of individuals with NAFLD compared to controls, by performing direct infusion lipidomics on serum biospecimens from a cohort study of adults in Mexico. A nested case-control study was conducted with a sample of 98 NAFLD cases and 100 healthy controls who are participating in an on-going, longitudinal study in Mexico. NAFLD cases were clinically confirmed using elevated liver enzyme tests and liver ultrasound or liver ultrasound elastography, after excluding alcohol abuse, and 100 controls were identified as having at least two consecutive normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (< 40 U/L) results in a 6-month period, and a normal liver ultrasound elastography result in January 2018. Samples were analyzed on the Sciex Lipidyzer Platform and quantified with normalization to serum volume. As many as 1100 lipid species can be identified using the Lipidyzer targeted multiple-reaction monitoring list. The association between serum lipids and NAFLD was investigated using analysis of covariance, random forest analysis, and by generating receiver operator characteristic (ROC) curves. NAFLD cases had differences in total amounts of serum cholesterol esters, lysophosphatidylcholines, sphingomyelins, and triacylglycerols (TAGs), however, other lipid subclasses were similar to controls. Analysis of individual TAG species revealed increased incorporation of saturated fatty acyl tails in serum of NAFLD cases. After adjusting for age, sex, body mass index, and PNPLA3 genotype, a combined panel of ten lipids predicted case or control status better than an area under the ROC curve of 0.83. These preliminary results indicate that the serum lipidome differs in patients with NAFLD, compared to healthy controls, and suggest that assessing the desaturation state of TAGs or a specific lipid panel may be useful clinical tools for the diagnosis of NAFLD.
ArticleNumber 136
Audience Academic
Author Glenn, Beth A.
Amoon, Aryana T.
Rivera-Paredez, Berenice
Sinsheimer, Janet S.
Huertas-Vazquez, Adriana
Saab, Sammy
Williams, Kevin J.
Salmerón, Jorge
Bensinger, Steven J.
Velazquez-Cruz, Rafael
Bastani, Roshan
Lusis, Aldons J.
Su, Baolong
Flores, Yvonne N.
May, Folasade P.
Ramírez-Palacios, Paula
Author_xml – sequence: 1
  givenname: Yvonne N.
  orcidid: 0000-0002-0601-357X
  surname: Flores
  fullname: Flores, Yvonne N.
– sequence: 2
  givenname: Aryana T.
  surname: Amoon
  fullname: Amoon, Aryana T.
– sequence: 3
  givenname: Baolong
  surname: Su
  fullname: Su, Baolong
– sequence: 4
  givenname: Rafael
  surname: Velazquez-Cruz
  fullname: Velazquez-Cruz, Rafael
– sequence: 5
  givenname: Paula
  surname: Ramírez-Palacios
  fullname: Ramírez-Palacios, Paula
– sequence: 6
  givenname: Jorge
  surname: Salmerón
  fullname: Salmerón, Jorge
– sequence: 7
  givenname: Berenice
  surname: Rivera-Paredez
  fullname: Rivera-Paredez, Berenice
– sequence: 8
  givenname: Janet S.
  surname: Sinsheimer
  fullname: Sinsheimer, Janet S.
– sequence: 9
  givenname: Aldons J.
  surname: Lusis
  fullname: Lusis, Aldons J.
– sequence: 10
  givenname: Adriana
  surname: Huertas-Vazquez
  fullname: Huertas-Vazquez, Adriana
– sequence: 11
  givenname: Sammy
  surname: Saab
  fullname: Saab, Sammy
– sequence: 12
  givenname: Beth A.
  surname: Glenn
  fullname: Glenn, Beth A.
– sequence: 13
  givenname: Folasade P.
  surname: May
  fullname: May, Folasade P.
– sequence: 14
  givenname: Kevin J.
  surname: Williams
  fullname: Williams, Kevin J.
– sequence: 15
  givenname: Roshan
  surname: Bastani
  fullname: Bastani, Roshan
– sequence: 16
  givenname: Steven J.
  surname: Bensinger
  fullname: Bensinger, Steven J.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34629052$$D View this record in MEDLINE/PubMed
BookMark eNp9kkuPFCEUhStmjPPQP-DCkLhxUyNQQFEuTCYTH5OMcaEm7sgtHt10qooWqNH-99Ld4zg9MYYFXPjuIQfOaXU0hclW1XOCzwmR4nUitGOsxpTUmHAqav6oOiGsLQtCvh_dWx9XpymtMKa4FeJJddwwQTvM6Um1-GLjPKLBr71JCKJFkFLQHrI16KfPS1QuhUGHZRi8Rg5y3hT6xkZkfLKQ7BsEaO2HkJEuVa3DlGMYUMqz2SA_oU_2l9fhafXYwZDss9v5rPr2_t3Xy4_19ecPV5cX17Xmosl1h61uJe06QhvMjSGEEkf7DhxvKe-xc20viQFGsW606HuHe05KwVojXYubs-pqr2sCrNQ6-hHiRgXwarcR4kJBzF4PVjVtb52QEktqGUDbccGKkOspA9JaUrTe7rXWcz9ao21xBsOB6OHJ5JdqEW6U5JhhJovAq1uBGH7MNmU1-qTtMMBkw5wU5RJ3vGGEF_TlA3QV5lhefkc1hEneNX-pBRQDfnKh3Ku3oupCSCKoEJ0o1Pk_qDKMHctXTNb5sn_Q8OK-0TuHf2JSALoHdAwpRevuEILVNotqn0VVsqh2WVRbS_JBk_YZst8GBPzwv9bfimrh1g
CitedBy_id crossref_primary_10_1021_acsomega_4c02433
crossref_primary_10_3389_fphar_2022_971561
crossref_primary_10_1360_SSV_2024_0084
crossref_primary_10_1038_s41419_023_06095_2
crossref_primary_10_3390_nu15071590
crossref_primary_10_1016_j_xcrm_2024_101853
crossref_primary_10_1186_s12916_023_02818_6
crossref_primary_10_1177_00033197221091317
crossref_primary_10_35366_117516
Cites_doi 10.1007/s11033-016-4058-z
10.3390/ijms18122550
10.1016/j.metabol.2010.03.006
10.1155/2010/170680
10.1002/hep.28953
10.1007/s00125-013-2981-2
10.1002/hep.23593
10.1016/j.cgh.2015.05.001
10.1021/pr201223p
10.1016/S2213-8587(14)70146-9
10.1194/jlr.P054387
10.1038/nrgastro.2013.149
10.1053/j.gastro.2018.06.031
10.3748/wjg.v25.i24.3009
10.1002/hep.23229
10.1016/S1665-2681(19)31922-2
10.1016/j.rgmx.2018.11.007
10.1016/j.xpro.2020.100235
10.1155/2016/2862173
10.1038/nrgastro.2013.182
10.1021/acs.analchem.7b05215
10.1002/hep.20466
10.1093/nar/gkv468
10.1371/journal.pgen.1001324
10.1021/pr1002593
10.1111/j.1440-1746.2004.03362.x
10.21149/spm.v58i6.8299
10.3892/br.2014.309
10.1016/j.ijsu.2014.07.013
10.1111/liv.12454
10.1186/s12986-017-0213-3
10.1016/S1590-8658(02)80194-3
10.1194/jlr.R800095-JLR200
10.1038/nrgastro.2017.109
10.1194/jlr.R008896
10.3390/nu11061336
10.1194/jlr.M033506
10.1371/journal.pone.0139559
10.1186/s13059-018-1439-8
10.1016/j.cgh.2018.05.057
10.1097/MEG.0b013e32832fcdf0
10.1038/s41591-018-0061-3
10.1371/journal.pone.0057165
10.1194/jlr.M085613
10.1016/j.freeradbiomed.2019.05.029
10.1016/j.yexmp.2018.01.001
10.1053/j.gastro.2010.09.038
10.1159/000282080
10.1016/j.cgh.2014.08.037
10.1002/hep.20554
10.1038/ajg.2013.104
10.1111/j.2517-6161.1995.tb02031.x
10.3748/wjg.v20.i17.4987
10.1002/hep.23594
10.2337/dc18-0071
10.1002/hep.29367
10.1002/ijc.25797
10.1038/ng.257
10.3945/jn.110.132332
10.1038/ng.970
10.1016/j.cgh.2016.05.046
10.1194/jlr.P056002
10.2337/dc18-S002
10.1172/jci.insight.127902
10.1161/CIRCULATIONAHA.109.192644
10.1016/j.cgh.2017.09.041
10.1016/j.metabol.2019.154005
10.1371/journal.pmed.1001255
10.1021/acs.analchem.7b01097
10.1016/j.jhep.2016.01.002
10.1186/1471-230X-12-84
10.3390/nu10091175
10.1159/000235677
10.1159/000318741
10.1111/liv.14507
10.1371/journal.pone.0022775
10.1016/j.orcp.2010.02.004
10.1002/hep.21763
ContentType Journal Article
Copyright 2021. The Author(s).
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. The Author(s).
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOA
DOI 10.1186/s12944-021-01526-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Sciences
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1476-511X
EndPage 17
ExternalDocumentID oai_doaj_org_article_37bef688082e4aa795640c4fb24a17e1
PMC8504048
A681626696
34629052
10_1186_s12944_021_01526_5
Genre Journal Article
GeographicLocations Mexico
United States--US
GeographicLocations_xml – name: Mexico
– name: United States--US
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: U2C-DK119886
– fundername: NIDDK NIH HHS
  grantid: U2C DK119886
– fundername: Consejo Nacional de Ciencia y Tecnología
  grantid: 26267M
– fundername: Consejo Nacional de Ciencia y Tecnología
  grantid: SALUD-2011-01-161930
– fundername: NCATS NIH HHS
  grantid: UL1 TR001881
– fundername: NHLBI NIH HHS
  grantid: HL146358
– fundername: NCI NIH HHS
  grantid: K07 CA197179
– fundername: NCATS NIH HHS
  grantid: UL1TR001881
– fundername: Division of Cancer Epidemiology and Genetics, National Cancer Institute
  grantid: K07CA197179
– fundername: NHLBI NIH HHS
  grantid: P01 HL146358
– fundername: ;
  grantid: 26267M; SALUD-2011-01-161930
– fundername: ;
  grantid: HL146358
– fundername: ;
  grantid: K07CA197179
– fundername: ;
  grantid: UL1TR001881
– fundername: ;
  grantid: U2C-DK119886
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAHBH
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
O5R
O5S
OK1
OVT
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
PMFND
3V.
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-90ec7829912305dd1121f2b9af5725b0ff7b81da420c3c6bbf0b5120c47d8f703
IEDL.DBID M48
ISSN 1476-511X
IngestDate Wed Aug 27 01:31:42 EDT 2025
Thu Aug 21 18:32:02 EDT 2025
Fri Jul 11 07:39:30 EDT 2025
Fri Jul 25 19:16:55 EDT 2025
Tue Jun 17 21:09:48 EDT 2025
Tue Jun 10 20:48:26 EDT 2025
Mon Jul 21 05:25:39 EDT 2025
Tue Jul 01 00:23:17 EDT 2025
Thu Apr 24 23:10:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Triacylglycerol desaturation
Mexican
NAFLD
Biomarkers
Lipidomics
Nonalcoholic fatty liver disease
Triglycerides
Cross-sectional study
Latinos
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-90ec7829912305dd1121f2b9af5725b0ff7b81da420c3c6bbf0b5120c47d8f703
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0601-357X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12944-021-01526-5
PMID 34629052
PQID 2583148593
PQPubID 42587
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_37bef688082e4aa795640c4fb24a17e1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8504048
proquest_miscellaneous_2580953415
proquest_journals_2583148593
gale_infotracmisc_A681626696
gale_infotracacademiconefile_A681626696
pubmed_primary_34629052
crossref_primary_10_1186_s12944_021_01526_5
crossref_citationtrail_10_1186_s12944_021_01526_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-10-10
PublicationDateYYYYMMDD 2021-10-10
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-10
  day: 10
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Lipids in health and disease
PublicationTitleAlternate Lipids Health Dis
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References FWB Sanders (1526_CR80) 2018; 19
K-T Khaw (1526_CR71) 2012; 9
BQ Starley (1526_CR3) 2010; 51
Y Benjamini (1526_CR60) 1995; 57
1526_CR42
DL Gorden (1526_CR43) 2015; 56
FVG Pedregosa (1526_CR61) 2011; 12
A Wree (1526_CR31) 2013; 10
ER Kallwitz (1526_CR12) 2015; 13
1526_CR82
E Denova-Gutiérrez (1526_CR51) 2010; 2010
SC Kalhan (1526_CR28) 2011; 60
P Puri (1526_CR26) 2009; 50
J Barr (1526_CR75) 2010; 9
Y Ogawa (1526_CR24) 2013; 71
JC Chambers (1526_CR36) 2011; 43
R Bernal-Reyes (1526_CR65) 2019; 84
M Orešič (1526_CR46) 2013; 56
Š Kr (1526_CR76) 2018; 90
SR Weston (1526_CR9) 2005; 41
K Lee (1526_CR21) 2010; 4
E Denova-Gutiérrez (1526_CR49) 2016; 58
C Xu (1526_CR15) 2013; 108
J Wattacheril (1526_CR79) 2013; 8
E von Elm (1526_CR48) 2014; 12
JD Browning (1526_CR7) 2004; 40
SH Park (1526_CR29) 2004; 19
MW Fleischman (1526_CR11) 2014; 20
J Frith (1526_CR18) 2009; 55
C Papandreou (1526_CR47) 2017; 14
E Denova-Gutiérrez (1526_CR50) 2011; 141
A Wree (1526_CR39) 2011; 83
M Tomizawa (1526_CR68) 2014; 2
EK Speliotes (1526_CR35) 2011; 7
L Caballería (1526_CR19) 2010; 22
J Yu (1526_CR40) 2016; 2016
D Amarapurkar (1526_CR17) 2007; 6
1526_CR73
WY Hsieh (1526_CR57) 2021; 2
Z Li (1526_CR74) 2017; 18
M Mongraw-Chaffin (1526_CR16) 2015; 10
S Saab (1526_CR10) 2016; 14
J Barr (1526_CR44) 2012; 11
Association AD (1526_CR55) 2018; 41
NG Forouhi (1526_CR70) 2014; 2
S Bellentani (1526_CR13) 2010; 28
E Fahy (1526_CR63) 2009; 50
NE Rich (1526_CR8) 2018; 16
S Romeo (1526_CR34) 2008; 40
NH Kim (1526_CR20) 2014; 34
K-Y Peng (1526_CR66) 2018; 59
N Perakakis (1526_CR67) 2019; 101
BK Ubhi (1526_CR58) 1730; 2018
A Lonardo (1526_CR23) 2002; 34
1526_CR64
QM Anstee (1526_CR33) 2013; 10
PK Luukkonen (1526_CR81) 2018; 41
Z Younossi (1526_CR1) 2018; 15
L Hoyles (1526_CR27) 2018; 24
S Qadri (1526_CR83) 2020; 40
N Chalasani (1526_CR2) 2018; 67
EK Speliotes (1526_CR22) 2010; 51
JM Mato (1526_CR41) 2019; 25
G Svegliati-Baroni (1526_CR72) 2019; 144
J Ertle (1526_CR4) 2011; 128
KC Sung (1526_CR14) 2012; 12
E Larrieta-Carrasco (1526_CR38) 2018; 104
AJ Hooper (1526_CR32) 2011; 52
DL Gorden (1526_CR45) 2011; 6
1526_CR54
1526_CR53
1526_CR52
T Metsalu (1526_CR59) 2015; 43
Z Hall (1526_CR78) 2017; 89
CD Williams (1526_CR6) 2011; 140
Z Younossi (1526_CR5) 2019; 17
VT Männistö (1526_CR30) 2014; 55
Z Hall (1526_CR77) 2017; 65
YN Flores (1526_CR37) 2016; 43
PK Luukkonen (1526_CR69) 2016; 64
KG Alberti (1526_CR56) 2009; 120
G Liebisch (1526_CR62) 2013; 54
P Puri (1526_CR25) 2007; 46
References_xml – volume: 43
  start-page: 1359
  issue: 12
  year: 2016
  ident: 1526_CR37
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-016-4058-z
– volume: 18
  start-page: 2550
  issue: 12
  year: 2017
  ident: 1526_CR74
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18122550
– volume: 60
  start-page: 404
  issue: 3
  year: 2011
  ident: 1526_CR28
  publication-title: Metab Clin Exp
  doi: 10.1016/j.metabol.2010.03.006
– volume: 2010
  start-page: 1
  year: 2010
  ident: 1526_CR51
  publication-title: J Nutr Metabol
  doi: 10.1155/2010/170680
– volume: 65
  start-page: 1165
  issue: 4
  year: 2017
  ident: 1526_CR77
  publication-title: Hepatology
  doi: 10.1002/hep.28953
– volume: 56
  start-page: 2266
  issue: 10
  year: 2013
  ident: 1526_CR46
  publication-title: Diabetologia
  doi: 10.1007/s00125-013-2981-2
– volume: 51
  start-page: 1979
  issue: 6
  year: 2010
  ident: 1526_CR22
  publication-title: Hepatology
  doi: 10.1002/hep.23593
– volume: 14
  start-page: 5
  year: 2016
  ident: 1526_CR10
  publication-title: Clinical Gastroenterology and Hepatology
  doi: 10.1016/j.cgh.2015.05.001
– volume: 11
  start-page: 2521
  issue: 4
  year: 2012
  ident: 1526_CR44
  publication-title: J Proteome Res
  doi: 10.1021/pr201223p
– volume: 2
  start-page: 810
  issue: 10
  year: 2014
  ident: 1526_CR70
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(14)70146-9
– volume: 55
  start-page: 2676
  issue: 12
  year: 2014
  ident: 1526_CR30
  publication-title: J Lipid Res
  doi: 10.1194/jlr.P054387
– volume: 10
  start-page: 627
  issue: 11
  year: 2013
  ident: 1526_CR31
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.149
– ident: 1526_CR73
  doi: 10.1053/j.gastro.2018.06.031
– volume: 25
  start-page: 3009
  issue: 24
  year: 2019
  ident: 1526_CR41
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v25.i24.3009
– volume: 50
  start-page: 1827
  issue: 6
  year: 2009
  ident: 1526_CR26
  publication-title: Hepatology
  doi: 10.1002/hep.23229
– volume: 6
  start-page: 161
  issue: 3
  year: 2007
  ident: 1526_CR17
  publication-title: Ann Hepatol
  doi: 10.1016/S1665-2681(19)31922-2
– volume: 84
  start-page: 69
  issue: 1
  year: 2019
  ident: 1526_CR65
  publication-title: Rev Gastroenterol Mex
  doi: 10.1016/j.rgmx.2018.11.007
– volume: 2
  start-page: 100235
  issue: 1
  year: 2021
  ident: 1526_CR57
  publication-title: STAR Protoc
  doi: 10.1016/j.xpro.2020.100235
– volume: 2016
  start-page: 1
  year: 2016
  ident: 1526_CR40
  publication-title: Gastroenterol Res Pract
  doi: 10.1155/2016/2862173
– volume: 10
  start-page: 645
  issue: 11
  year: 2013
  ident: 1526_CR33
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.182
– volume: 90
  start-page: 5130
  year: 2018
  ident: 1526_CR76
  publication-title: Anal Chem
  doi: 10.1021/acs.analchem.7b05215
– volume: 40
  start-page: 1387
  issue: 6
  year: 2004
  ident: 1526_CR7
  publication-title: Hepatology
  doi: 10.1002/hep.20466
– volume: 43
  start-page: W566
  issue: W1
  year: 2015
  ident: 1526_CR59
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkv468
– volume: 71
  start-page: 1623
  issue: 9
  year: 2013
  ident: 1526_CR24
  publication-title: Nihon Rinsho
– volume: 7
  issue: 3
  year: 2011
  ident: 1526_CR35
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1001324
– volume: 9
  start-page: 4501
  issue: 9
  year: 2010
  ident: 1526_CR75
  publication-title: J Proteome Res
  doi: 10.1021/pr1002593
– volume: 19
  start-page: 694
  issue: 6
  year: 2004
  ident: 1526_CR29
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2004.03362.x
– volume: 58
  start-page: 708
  issue: 6
  year: 2016
  ident: 1526_CR49
  publication-title: Salud Publica Mex
  doi: 10.21149/spm.v58i6.8299
– volume: 2
  start-page: 633
  issue: 5
  year: 2014
  ident: 1526_CR68
  publication-title: Biomedical Reports
  doi: 10.3892/br.2014.309
– volume: 12
  start-page: 1495
  issue: 12
  year: 2014
  ident: 1526_CR48
  publication-title: Int J Surg
  doi: 10.1016/j.ijsu.2014.07.013
– volume: 34
  start-page: 604
  issue: 4
  year: 2014
  ident: 1526_CR20
  publication-title: Liver Int
  doi: 10.1111/liv.12454
– volume: 14
  start-page: 58
  issue: 1
  year: 2017
  ident: 1526_CR47
  publication-title: Nutrition & Metabolism
  doi: 10.1186/s12986-017-0213-3
– volume: 34
  start-page: 204
  issue: 3
  year: 2002
  ident: 1526_CR23
  publication-title: Dig Liver Dis
  doi: 10.1016/S1590-8658(02)80194-3
– volume: 50
  start-page: S9
  issue: Suppl
  year: 2009
  ident: 1526_CR63
  publication-title: J Lipid Res
  doi: 10.1194/jlr.R800095-JLR200
– volume: 15
  start-page: 11
  issue: 1
  year: 2018
  ident: 1526_CR1
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2017.109
– volume: 52
  start-page: 593
  issue: 4
  year: 2011
  ident: 1526_CR32
  publication-title: J Lipid Res
  doi: 10.1194/jlr.R008896
– ident: 1526_CR53
  doi: 10.3390/nu11061336
– volume: 54
  start-page: 1523
  issue: 6
  year: 2013
  ident: 1526_CR62
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M033506
– volume: 10
  issue: 10
  year: 2015
  ident: 1526_CR16
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0139559
– volume: 19
  start-page: 79
  issue: 1
  year: 2018
  ident: 1526_CR80
  publication-title: Genome Biol
  doi: 10.1186/s13059-018-1439-8
– volume: 2018
  start-page: 227
  year: 1730
  ident: 1526_CR58
  publication-title: Methods Mol Biol
– volume: 17
  start-page: 748
  issue: 4
  year: 2019
  ident: 1526_CR5
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2018.05.057
– volume: 22
  start-page: 24
  issue: 1
  year: 2010
  ident: 1526_CR19
  publication-title: Eur J Gastroenterol Hepatol
  doi: 10.1097/MEG.0b013e32832fcdf0
– volume: 24
  start-page: 1070
  issue: 7
  year: 2018
  ident: 1526_CR27
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0061-3
– volume: 8
  issue: 2
  year: 2013
  ident: 1526_CR79
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0057165
– volume: 59
  start-page: 1977
  issue: 10
  year: 2018
  ident: 1526_CR66
  publication-title: J Lipid Res
  doi: 10.1194/jlr.M085613
– volume: 144
  start-page: 293
  year: 2019
  ident: 1526_CR72
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2019.05.029
– volume: 12
  start-page: 2825
  year: 2011
  ident: 1526_CR61
  publication-title: J Mach Learn Res
– volume: 104
  start-page: 50
  issue: 1
  year: 2018
  ident: 1526_CR38
  publication-title: Experimental Molecular Pathology
  doi: 10.1016/j.yexmp.2018.01.001
– volume: 140
  start-page: 124
  issue: 1
  year: 2011
  ident: 1526_CR6
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.09.038
– volume: 28
  start-page: 155
  issue: 1
  year: 2010
  ident: 1526_CR13
  publication-title: Dig Dis
  doi: 10.1159/000282080
– volume: 13
  start-page: 569
  issue: 3
  year: 2015
  ident: 1526_CR12
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2014.08.037
– volume: 41
  start-page: 372
  issue: 2
  year: 2005
  ident: 1526_CR9
  publication-title: Hepatology
  doi: 10.1002/hep.20554
– volume: 108
  start-page: 1299
  issue: 8
  year: 2013
  ident: 1526_CR15
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2013.104
– volume: 57
  start-page: 289
  year: 1995
  ident: 1526_CR60
  publication-title: J R Stat Soc Ser B Methodol
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 20
  start-page: 4987
  issue: 17
  year: 2014
  ident: 1526_CR11
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i17.4987
– volume: 51
  start-page: 1820
  issue: 5
  year: 2010
  ident: 1526_CR3
  publication-title: Hepatology
  doi: 10.1002/hep.23594
– volume: 41
  start-page: 1732
  issue: 8
  year: 2018
  ident: 1526_CR81
  publication-title: Diabetes Care
  doi: 10.2337/dc18-0071
– volume: 67
  start-page: 328
  issue: 1
  year: 2018
  ident: 1526_CR2
  publication-title: Hepatology
  doi: 10.1002/hep.29367
– volume: 128
  start-page: 2436
  issue: 10
  year: 2011
  ident: 1526_CR4
  publication-title: Int J Cancer
  doi: 10.1002/ijc.25797
– volume: 40
  start-page: 1461
  issue: 12
  year: 2008
  ident: 1526_CR34
  publication-title: Nat Genet
  doi: 10.1038/ng.257
– volume: 141
  start-page: 921
  issue: 5
  year: 2011
  ident: 1526_CR50
  publication-title: J Nutr
  doi: 10.3945/jn.110.132332
– ident: 1526_CR64
– volume: 43
  start-page: 1131
  issue: 11
  year: 2011
  ident: 1526_CR36
  publication-title: Nat Genet
  doi: 10.1038/ng.970
– ident: 1526_CR42
  doi: 10.1016/j.cgh.2016.05.046
– volume: 56
  start-page: 722
  issue: 3
  year: 2015
  ident: 1526_CR43
  publication-title: J Lipid Res
  doi: 10.1194/jlr.P056002
– volume: 41
  start-page: S13
  issue: Supplement 1
  year: 2018
  ident: 1526_CR55
  publication-title: Diabetes Care
  doi: 10.2337/dc18-S002
– ident: 1526_CR82
  doi: 10.1172/jci.insight.127902
– volume: 120
  start-page: 1640
  issue: 16
  year: 2009
  ident: 1526_CR56
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.192644
– volume: 16
  start-page: 198
  year: 2018
  ident: 1526_CR8
  publication-title: Clinical Gastroenterology and Hepatology
  doi: 10.1016/j.cgh.2017.09.041
– volume: 101
  start-page: 154005
  year: 2019
  ident: 1526_CR67
  publication-title: Metab Clin Exp
  doi: 10.1016/j.metabol.2019.154005
– volume: 9
  start-page: e1001255
  issue: 7
  year: 2012
  ident: 1526_CR71
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001255
– volume: 89
  start-page: 5161
  issue: 9
  year: 2017
  ident: 1526_CR78
  publication-title: Anal Chem
  doi: 10.1021/acs.analchem.7b01097
– volume: 64
  start-page: 1167
  issue: 5
  year: 2016
  ident: 1526_CR69
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.01.002
– volume: 12
  start-page: 84
  year: 2012
  ident: 1526_CR14
  publication-title: BMC Gastroenterology
  doi: 10.1186/1471-230X-12-84
– ident: 1526_CR52
  doi: 10.3390/nu10091175
– ident: 1526_CR54
– volume: 55
  start-page: 607
  issue: 6
  year: 2009
  ident: 1526_CR18
  publication-title: Gerontology
  doi: 10.1159/000235677
– volume: 83
  start-page: 124
  issue: 1-2
  year: 2011
  ident: 1526_CR39
  publication-title: Digestion
  doi: 10.1159/000318741
– volume: 40
  start-page: 2128
  issue: 9
  year: 2020
  ident: 1526_CR83
  publication-title: Liver Int
  doi: 10.1111/liv.14507
– volume: 6
  issue: 8
  year: 2011
  ident: 1526_CR45
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0022775
– volume: 4
  start-page: e217
  issue: 3
  year: 2010
  ident: 1526_CR21
  publication-title: Obes Res Clin Pract
  doi: 10.1016/j.orcp.2010.02.004
– volume: 46
  start-page: 1081
  issue: 4
  year: 2007
  ident: 1526_CR25
  publication-title: Hepatology
  doi: 10.1002/hep.21763
SSID ssj0020766
Score 2.3224418
Snippet Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism and known...
Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid metabolism...
Abstract Background Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease and cirrhosis. NAFLD is mediated by changes in lipid...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 136
SubjectTerms Abuse
Adult
Aged
Alanine
Alanine transaminase
Alcohol abuse
Aspartate aminotransferase
Biomarkers
Biomarkers - blood
Blood lipids
Blood pressure
Body mass index
Case-Control Studies
Cholesterol
Cholesterol - blood
Chronic illnesses
Cirrhosis
Cohort Studies
Complications and side effects
Cross-sectional studies
Development and progression
Diabetes
Diabetes mellitus
Diagnosis
Drug abuse
Esters
Fatty acids
Fatty liver
Female
Genotypes
Glucose
Health aspects
Health care
Hepatitis
High density lipoprotein
Hispanic Americans
Humans
Laboratories
Lipid composition
Lipid metabolism
Lipidomics
Lipids
Liver cirrhosis
Liver diseases
Lysophosphatidylcholines - blood
Male
Measurement
Metabolic syndrome
Mexico
Middle Aged
NAFLD
Non-alcoholic Fatty Liver Disease - blood
Nonalcoholic fatty liver disease
Physiological aspects
Risk factors
ROC Curve
Serum lipids
Sphingomyelins - blood
Triacylglycerol desaturation
Triglycerides
Triglycerides - blood
Ultrasonic imaging
Ultrasound
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLgpZHoCAjITigqIlfSXpbEFWFVE5U6s3yEyJt01U3K9F_3xnHu9oICS4cE48lezyemS-efCbkfehkFTsbSudlLEUAuGOi8KXxMTjuDXLWYbXFd3V-Kb5dyau9q76wJmyiB54Ud8IbG6ICK2tZEMY0kM-LyolomTB1ExLwgZi3BVMZagE6V9tfZFp1soaoJkSJ5QgQ_pgq5SwMJbb-P33yXlCaF0zuRaCzJ-RxTh3pYhryU_IgDIfkaDEAbL6-ox9oKuZMX8kPycOLfGZ-RH6CO9hc02W_6v2amttATV6S4Cl-hqUDZuPpptze0WjG8Q6kwcRpPr05pYau-uXNSB08lbm6nSZmWtoP9CL8Bnt6Ri7Pvv74cl7m6xVKJxUfy64KDvIDSBABhkjvIfOqI7OdibJh0lYxNhayWSNY5bhT1sbKQnoAym98G8FTPCcHMMDwklBhXPBIW2MqjmwzHee2wTNtFa0LtSxIvdW2dpl7HK_AWOqEQVqlpxXSsEI6rZCGPp92fVYT88ZfpT_jIu4kkTU7vQBb0tmW9L9sqSAf0QQ07m0YnjP5FwWYJLJk6YVqawCAqlMFOZ5Jwp508-atEensE9aayZYD-ATlFOTdrhl7Yp3bEG42SQYJAAWq7MVkc7spcaFYV0lWkGZmjbM5z1uG_ldiDG8l-GrRvvofSnpNHjHcSFjVUx2Tg_F2E95AYjbat2kP3gPbKDQc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB60gvgi2npZrTKC6IOEJnNL4ousYilCfbKwb8Nca2CbXXezYP-958zObhuEPiZzBmZy7jMn3yHkfWhlGVsbCudlLESAdMdE4QvjY3DcG8Ssw2qLn-rsQvyYyVk-cFvnssqdTUyG2i8cnpGfMNlwCN1ly78s_xTYNQpvV3MLjfvkAUKXoVTXs5uEC3J0tftRplEna_BtQhRYlABOkKlCjpxRwuz_3zLfck3jsslbfuj0CXmcA0g63XL8KbkX-kNyNO0heb66ph9oKulMZ-WH5OF5vjk_IpdgFDZXdN4tO7-mZhWoyYwJnuJhLO0xJk_9cjtHoxmGa6AGQaf5DuczNXTZzRcDdfBU5Bp3mvBpadfT8_AXpOoZuTj9_uvbWZGbLBROKj4UbRkcRAkQJkIyIr2H-KuKzLYmyppJW8ZYW4hpjWCl405ZG0sLQULpRO2bCPbiOTmABYaXhArjgkfwGlNyxJxpObc13myraF2o5IRUu6-tXUYgx0YYc50ykUbpLYc0cEgnDmmY82k_Z7nF37iT-isycU-J2NnpxWJ1qbMqal7bEBXYrYYFYUwNGaKA7UTLhKnqUE3IRxQBjRoOy3Mm_6gAm0SsLD1VTQVpoGrVhByPKEEz3Xh4J0Q6W4a1vpHjCXm3H8aZWO3Wh8Um0SAMoMBP9mIrc_stcaFYW0o2IfVIGkd7Ho_03e-EG95IsNiieXX3sl6TRwxVBKt2ymNyMKw24Q0EXoN9m7TrH1QcK-4
  priority: 102
  providerName: ProQuest
Title Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico
URI https://www.ncbi.nlm.nih.gov/pubmed/34629052
https://www.proquest.com/docview/2583148593
https://www.proquest.com/docview/2580953415
https://pubmed.ncbi.nlm.nih.gov/PMC8504048
https://doaj.org/article/37bef688082e4aa795640c4fb24a17e1
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBa9QOnL2NpdsnVBg7E9DG--6GIPxkhHSxmkjLFA34QkS60hdbLEgebf7xzFDjUre9ijrXPAks5VOv4OIW9dwWNfGBfZkvuIOUh3tGdlpEvvbFZqxKzDaotLcTFh36_41Q7p2h21C7h8MLXDflKTxfTj3e_1V1D4L0Hhc_FpCT6LsQiLDcC5pSLiu2QfPJPEjgZjtr1VSCFnF92PMw_yHZKDjIm0iHna81MBzv9vo33Pa_UrKu-5qPPH5FEbW9LRRhiekB1XH5HjUQ159e2avqOh2jMcox-Rg3F7qX5MrsFerG7ptJpX5ZLqhaO63TNXUjynpTWG66GVbmWp102zBmrQAdpe73ymms6r6ayhFp6itvydBuhaWtV07O5A4J6SyfnZr28XUdt_IbJcZE1UxM5CAAERJOQpvCwhNEt8agrtuUy5ib2XBsJdzdLYZlYY42MD8UNsmSxzD6bkGdmDD3QvCGXauhJxbXScIRxNkWVG4qW38Ma6hA9I0q22si04OfbImKqQpORCbTZLwWapsFkKeD5seeYbaI5_Up_iJm4pEVY7vJgtrlWrpSqTxnkBJi1PHdNaQvLIYDrepEwn0iUD8h5FQKE4wudZ3f7DAJNEGC01EnkCGaIoxICc9ChBaW1_uBMi1cm8SnmeQXYKizMgb7bDyImFcLWbrQINIgQyXLLnG5nbTqkT3QGRPWnszbk_Ulc3AVI852DMWf7yvzlfkcMUFQlrfeITstcsVu41hGuNGZJdeSWHZP_07PLHz2E49BgGvfwD6o0_yg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGkIAXBBuXwgAjcXlA0RLHdhIkhMpl6ti6p03am2c79ojUtaVNBf1T_EbOcZNuEdLe9tj4uPLlXO3j7xDyxhUi9oVxkS2Fj7iDcEd7Xka69M6mpUbMOsy2OJKDE_7jVJxukL_tWxhMq2x1YlDU5cTiGfkuE3kKrrso0s_TXxFWjcLb1baExootDtzyN4Rs80_732B_3zK29_346yBqqgpEVsi0jorYWTCL4BeB9y3KEhyOxDNTaC8yJkzsfWbAidOcxTa10hgfG7CKseVZmXsQEPjfW-Q2GN4Yg73s9DLAizMp24c5udydgy3lPMIkCDC6TEaiY_xCjYD_LcEVU9hN07xi9_YekPuNw0r7Kw57SDbceIts98cQrF8s6TsaUkjD2fwWuTNsbuq3yTkoocUFHVXTqpxTPXNUN4zgSoqHv3SMMUCoz1tZ6nVdL4EaBIs2d0YfqabTajSpqYVfUZNTTwMeLq3GdOj-ABc_Iic3svyPySYM0D0llGvrSgTL0XGKGDdFmpoMb9KlN9YlokeSdrWVbRDPsfDGSIXIJ5dqtUMKdkiFHVLQ58O6z3SF93Et9RfcxDUlYnWHD5PZuWpEX6WZcV6CnsyZ41pnEJFymI43jOskc0mPvEcWUKhRYHhWNw8jYJKIzaX6Mk8g7JSF7JGdDiVoAtttbplINZpori7lpkder5uxJ2bXjd1kEWgQdpDjkj1Z8dx6SimXrIgF65Gsw42dOXdbxtXPgFOeC7AQPH92_bBekbuD4-GhOtw_OnhO7jEUF8wYinfIZj1buBfg9NXmZZA0Ss5uWrT_AcoVaAM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lipids+are+associated+with+nonalcoholic+fatty+liver+disease%3A+a+pilot+case-control+study+in+Mexico&rft.jtitle=Lipids+in+health+and+disease&rft.au=Flores%2C+Yvonne+N.&rft.au=Amoon%2C+Aryana+T.&rft.au=Su%2C+Baolong&rft.au=Velazquez-Cruz%2C+Rafael&rft.date=2021-10-10&rft.pub=BioMed+Central&rft.eissn=1476-511X&rft.volume=20&rft_id=info:doi/10.1186%2Fs12944-021-01526-5&rft_id=info%3Apmid%2F34629052&rft.externalDocID=PMC8504048
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon